Clinical Trial: Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
Sponsor and Collaborators
Cancer and Leukemia Group B
National Cancer Institute (NCI)
Principal Investigator
Study Chair: Ghassan Abou-Alfa, MD Memorial Sloan-Kettering Cancer Center
ClinicalTrials.gov Identifier
NCT01015833